AllianceBernstein’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$63.9M Sell
94,484
-4,898
-5% -$3.14M 0.02% 525
2025
Q4
$67.2M Buy
99,382
+271
+0.3% +$185K 0.02% 536
2025
Q3
$63.3M Sell
99,111
-9,687
-9% -$5.88M 0.02% 551
2025
Q2
$58.4M Sell
108,798
-73,094
-40% -$35M 0.02% 561
2025
Q1
$76.4M Sell
181,892
-1,057,328
-85% -$459M 0.03% 454
2024
Q4
$512M Sell
1,239,220
-1,578,489
-56% -$692M 0.17% 98
2024
Q3
$1.42B Sell
2,817,709
-326,838
-10% -$159M 0.48% 35
2024
Q2
$1.53B Buy
3,144,547
+154,143
+5% +$77.4M 0.53% 30
2024
Q1
$1.61B Buy
2,990,404
+52,644
+2% +$28.8M 0.57% 28
2023
Q4
$1.63B Sell
2,937,760
-388,256
-12% -$182M 0.63% 27
2023
Q3
$1.45B Sell
3,326,016
-266,816
-7% -$133M 0.62% 28
2023
Q2
$1.8B Buy
3,592,832
+214,529
+6% +$103M 0.74% 22
2023
Q1
$1.69B Buy
3,378,303
+137,593
+4% +$65.8M 0.72% 22
2022
Q4
$1.32B Buy
3,240,710
+334,020
+11% +$130M 0.6% 24
2022
Q3
$947M Buy
2,906,690
+128,011
+5% +$47M 0.46% 39
2022
Q2
$975M Buy
2,778,679
+839,182
+43% +$342M 0.45% 40
2022
Q1
$1.06B Buy
1,939,497
+343,189
+21% +$181M 0.41% 42
2021
Q4
$1.05B Buy
1,596,308
+254,033
+19% +$159M 0.37% 49
2021
Q3
$835M Buy
1,342,275
+110,305
+9% +$74.1M 0.33% 55
2021
Q2
$778M Sell
1,231,970
-113,121
-8% -$62.5M 0.31% 60
2021
Q1
$658M Sell
1,345,091
-42,890
-3% -$21.5M 0.29% 65
2020
Q4
$694M Buy
1,387,981
+34,000
+3% +$15.2M 0.33% 58
2020
Q3
$532M Buy
1,353,981
+42,043
+3% +$15.5M 0.29% 67
2020
Q2
$433M Buy
1,311,938
+47,662
+4% +$13.8M 0.25% 76
2020
Q1
$306M Buy
1,264,276
+1,113,849
+740% +$291M 0.22% 93
2019
Q4
$39.3M Sell
150,427
-4,454
-3% -$1.17M 0.02% 605
2019
Q3
$42.1M Buy
154,881
+14,325
+10% +$3.99M 0.03% 575
2019
Q2
$38.7M Sell
140,556
-2,251
-2% -$555K 0.02% 613
2019
Q1
$31.9M Sell
142,807
-1,798
-1% -$371K 0.02% 664
2018
Q4
$26.9M Sell
144,605
-614
-0.4% -$126K 0.02% 658
2018
Q3
$36.3M Sell
145,219
-24,062
-14% -$5.84M 0.02% 621
2018
Q2
$36.9M Buy
169,281
+2,883
+2% +$594K 0.03% 612
2018
Q1
$31.8M Buy
166,398
+18,782
+13% +$3.47M 0.02% 629
2017
Q4
$23.1M Sell
147,616
-2,917
-2% -$459K 0.02% 724
2017
Q3
$23.4M Sell
150,533
-691
-0.5% -$109K 0.02% 719
2017
Q2
$24.4M Sell
151,224
-2,352
-2% -$382K 0.02% 687
2017
Q1
$23.7M Buy
153,576
+88,499
+136% +$12.2M 0.02% 684
2016
Q4
$7.63M Sell
65,077
-714
-1% -$81.5K 0.01% 1005
2016
Q3
$7.42M Sell
65,791
-120
-0.2% -$12.6K 0.01% 977
2016
Q2
$6.12M Buy
65,911
+520
+0.8% +$44.7K 0.01% 995
2016
Q1
$5.12M Sell
65,391
-65
-0.1% -$4.68K ﹤0.01% 1049
2015
Q4
$4.77M Sell
65,456
-1,418
-2% -$101K ﹤0.01% 1075
2015
Q3
$4.96M Sell
66,874
-7,532
-10% -$539K ﹤0.01% 1061
2015
Q2
$4.77M Sell
74,406
-634
-0.8% -$43.9K ﹤0.01% 1141
2015
Q1
$5.8M Sell
75,040
-3,840
-5% -$299K ﹤0.01% 1055
2014
Q4
$5.85M Sell
78,880
-2,000
-2% -$140K ﹤0.01% 1050
2014
Q3
$4.76M Sell
80,880
-468
-0.6% -$29.6K ﹤0.01% 1114
2014
Q2
$5.43M Sell
81,348
-2,852
-3% -$181K ﹤0.01% 1093
2014
Q1
$5.11M Sell
84,200
-12,270
-13% -$731K ﹤0.01% 1126
2013
Q4
$5.13M Sell
96,470
-1,434
-1% -$75.5K ﹤0.01% 1097
2013
Q3
$4.88M Sell
97,904
-31,486
-24% -$1.51M ﹤0.01% 1084
2013
Q2
$5.81M Buy
+129,390
New +$5.65M 0.01% 940

Other funds holding IDXX

AllianceBernstein's IDXX Position: Q1 2026 in Review

AllianceBernstein reduced its Idexx Laboratories (IDXX) stake by 4.9% in Q1 2026, selling an estimated $3.14M and leaving 94,484 shares worth $63.9M. The position accounts for 0.02% of the portfolio, ranked #525.

AllianceBernstein first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.8B in Q2 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • AllianceBernstein held 94,484 shares of Idexx Laboratories worth $63.9M as of Q1 2026.
  • AllianceBernstein sold 4,898 Idexx Laboratories shares in Q1 2026, an estimated $3.14M.
  • Idexx Laboratories made up 0.02% of AllianceBernstein's portfolio in Q1 2026, its #525 holding.
  • AllianceBernstein first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • AllianceBernstein's Idexx Laboratories position peaked at $1.8B in Q2 2023.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.